Search Results
Results found for "Vlaams Instituut Biotechnologie"
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Brusle, Brussels, Belgium, has been named the winner of Brandeis’ 24th Jacob and Louise Gabbay Award in Biotechnology of one of the biggest classes of pharmaceutical targets by combining structural biology and advanced biotechnology
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development
- Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...
July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional
- Dr. Thomas P. Sakmar receives an honorary doctorate from Karolinska Institute
November 2021 "So proud and grateful to receive honorary doctorate yesterday from Karolinska Institute
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies #drugdiscovery #biotechnology
- Tectonic Therapeutic Strengthens Leadership Team
July 19, 2022 07:00 AM Eastern Daylight Time BOSTON--Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
than three decades of experience leading sales and marketing operations for both global and domestic biotechnology
- 📰 GPCR Weekly News, January 1 to 7, 2024
Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases Present at Biotech Showcase™ 2024 Establishing our first international translational research project - Institute
- First in Human: Early-stage COVID therapies hold promise against omicron variant
December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and
- Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...
platform, today announced it has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology
- 📰 GPCR Weekly News - January 2 to 8, 2023
GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- 📰 GPCR Weekly News, April 17 to 23, 2023
pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology
- 📰 GPCR Weekly News - January 9 to 15, 2023
GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
any legal entity in Ukraine (for example, schools and universities, research centers, governmental institutions grants to Ukrainian researchers who have been recently displaced by the war, or those who can travel to institutions
- 📰 GPCR Weekly News, May 20 to 26, 2024
receptor 3 Industry News New cannabinoid CB1 receptor antagonists disclosed in Inversago patent Orion Biotechnology
- 📰 GPCR Weekly News, April 3 to 9, 2023
Industry News Orion Biotechnology at the AACR 2023.
- 📰 GPCR Weekly News, February 5 to 11, 2024
Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients Orion Biotechnology
- 📰 GPCR Weekly News, January 8 to 14, 2024
Learning Model Three GPCR Companies Earn Prestigious Best Places to Work Certification in 2023 Orion Biotechnology
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Trends in Biotechnology , 29 (9), 435–442. https://doi.org/10.1016/j.tibtech.2011.04.003 Fowler, D.
- 📰 GPCR Weekly News, April 24 to 30, 2023
Industry News Orion Biotechnology will be participating in a panel discussion at the LSX World Congress
- From DNA day to GPCR genomics
Since then, the National Human Genome Research Institute (NHGRI) has supported annual events across the References National Human Genome Research Institute, U. S. (2002) National Human Genome Research Institute.
- 📰 GPCR Weekly News, April 15 to 21, 2024
Visit in its clinical phase 2b trial with AEF0117 for the treatment of cannabis use disorder Orion Biotechnology
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry from The Franklin Institute by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry from The Franklin Institute
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
superior choice for GPCR calcium signalling GPCR: Structural Insights and Role in Drug Discovery Orion Biotechnology
- From Failed Experiments to Predictive GPCR Models
When he moved to Uppsala in the late 1990s to study engineering, it was biotechnology—then on the rise—that
- 📰 GPCR Weekly News, February 19 to 25, 2024
in Upcoming Investor and Industry Conferences Sosei and IPJ to become Nxera Pharma from April Orion Biotechnology
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
To solve this industry-wide problem, Orion Biotechnology (Orion) is introducing a novel solution driven About Orion Biotechnology Orion’s mission is to unlock the therapeutic potential of previously undruggable For more information, follow Orion Biotechnology on LinkedIn or visit www.orionbiotechnology.com.
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
In addition, through a collaboration with the National Institutes of Health, the Company is also exploring








